Corcept Therapeutics
CORT
#2060
Rank
S$11.97 B
Marketcap
S$113.63
Share price
0.99%
Change (1 day)
49.85%
Change (1 year)

Market capitalization of Corcept Therapeutics (CORT)

Market cap: S$11.97 Billion

As of December 2025 Corcept Therapeutics has a market cap of S$11.97 Billion. This makes Corcept Therapeutics the world's 2060th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Corcept Therapeutics from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025S$11.97 B60.23%
2024S$7.47 B69%
2023S$4.42 B50.86%
2022S$2.93 B-5.16%
2021S$3.09 B-23.13%
2020S$4.02 B115.16%
2019S$1.86 B-11%
2018S$2.09 B-23.84%
2017S$2.75 B136.29%
2016S$1.16 B51.05%
2015S$0.77 B92.16%
2014S$0.40 B-1.02%
2013S$0.40 B132.65%
2012S$0.17 B-53.21%
2011S$0.37 B3.63%
2010S$0.36 B47.65%
2009S$0.24 B235.9%
2008S$72.58 M-58.72%
2007S$0.17 B262.33%
2006S$48.53 M-64.73%
2005S$0.13 B-40.4%
2004S$0.23 B

End of Day market cap according to different sources

On Dec 12th, 2025 the market cap of Corcept Therapeutics was reported to be:

S$11.95 Billion
by Nasdaq info icon info icon
S$11.97 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$658.30 B 5,398.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$137.78 B 1,050.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$328.49 B 2,643.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$1.189 T 9,834.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$189.80 B 1,485.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$323.53 B 2,602.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$1.17 B-90.16%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
S$2.35 B-80.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$13.22 B 10.46%๐Ÿ‡บ๐Ÿ‡ธ USA